medigraphic.com
SPANISH

Revista Mexicana de Mastología

ISSN 1870-2821 (Print)
Organo Oficial de la Asociación Mexicana de Mastología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2017, Number 1

<< Back Next >>

Rev Mex Mastol 2017; 7 (1)

Metaplastic breast carcinoma producer of chondroid uterus

López ZJ, Cerón LMA, Ornelas SPA
Full text How to cite this article

Language: Spanish
References: 7
Page: 15-18
PDF size: 236.02 Kb.


Key words:

Metaplastic carcinoma, biphasic tumor, chondroid matrix.

ABSTRACT

Metaplastic carcinoma breast is a type of malignancy very rare (‹ 1% of all breast cancer). It has invasiveness and high histological grade. It is characterized by associating a squamous epithelial component and a sarcomatoid component or with a variable phenotype (bone matrix, Chondroid or fusiform). We report the case of women 52 years old diagnosed with metaplastic carcinoma chondroid matrix producer with infiltrating ductal carcinoma treated with Modified Radical Mastectomy and adjuvant chemotherapy FEC 6 cycles plus radiotherapy with 50 Gy in 25Fx. Present recurrence sternum and retrosternal with chondroid tumor activity, so second was taken with Docetaxel, so far with good response and stable disease, is in surveillance and monitoring.


REFERENCES

  1. Golshan M, Kuten A, William J, Richardson A, Modarressi A, Matulonis U. Metaplastic carcinoma of the breast with neuroglial differentiation. Breast. 2006; 15 (4): 545-549.

  2. Rayson D, Adjei A, Summer VJ, Wold LE, Ingle JN. Met plastic breast cancer: Prognosis and response to systemic therapy. Ann Oncol. 1999; 10 (4): 413-419.

  3. Amillano K, Elorriaga K, Alberro J, Martín A, Rezola R, Plazaola A. Carcinoma metaplásico de mama. Revisión a propósito de un caso. Oncología. 2004; 27: 548-552.

  4. Iturriaga A, de Llano P, Arechea M, Beloquí R, Gómez M, Martínez J. Carcinoma metaplásico de mama variante “productor de matriz”. Expresión de CD99 y P63. Congreso Virtual Hispanoamericano de Anatomía Patológica. 2005: 1-6 http://www.conganat.org/7congreso/PDF/289.pdf.

  5. Niño-Hernández LM, García-Toloza R, Donado F, Pérez J, Arteta-Acosta C, Aroca G. Carcinoma metaplásico de la mama tipo células escamosas: reporte de caso y revisión de la literatura. Revista Colombiana de Obstetricia y Ginecología. 2011; 62 (3): 261-266.

  6. Jung SY, Kim HY, Nam BH, Min SY, Park C, Kwon Y et al. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Breast Cancer Res Treat. 2010; 120: 627-637.

  7. Lazo Valladares L, Fallas Muñoz M, Alfaro Alcocer E. Carcinoma metaplásico de mama. Revisión de 6 casos diagnosticados en el hospital de México, durante el periodo 2000-2006. AMC. 2007; 49 (4): 226-229.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Mastol. 2017;7